Breaking News Instant updates and real-time market news.

2020-05-01 08:06:02 AMZN Amazon.com $2,467.00 / +96.7 (+4.08%) 08:06 05/01/20 05/01 08:06 05/01/20 08:06	Amazon.com price target raised to $2,700 from $2,250 at Guggenheim Guggenheim analyst Robert Drbul raised the firm's price target on Amazon.com to $2,700 from $2,250 and keeps a Buy rating on the shares as he expects the outsized growth that picked up in March to persist in Q2, and likely to come across broader categories. He expects Amazon's retail positioning to improve further as a result of this crisis and sees it expanding its leadership moats across industries, Drbul added.	27 May 14 Sep
AMZN Amazon.com $2,467.00 / +96.7 (+4.08%) 05/01/20 Susquehanna Amazon.com price target raised to $3000 from $2500 at Susquehanna 05/01/20 Morgan Stanley Amazon.com price target raised to $2,600 from $2,400 at Morgan Stanley 05/01/20 KeyBanc Amazon.com price target raised to $2,700 from $2,400 at KeyBanc 05/01/20 Stifel Stifel says Amazon 'doing all the right things for society'

2020-05-01 08:06:02

AMZN

Amazon.com

$2,467.00 / +96.7 (+4.08%)

08:06

05/01/20

05/01

08:06

05/01/20

08:06

Amazon.com price target raised to $2,700 from $2,250 at Guggenheim

Guggenheim analyst Robert Drbul raised the firm's price target on Amazon.com to $2,700 from $2,250 and keeps a Buy rating on the shares as he expects the outsized growth that picked up in March to persist in Q2, and likely to come across broader categories. He expects Amazon's retail positioning to improve further as a result of this crisis and sees it expanding its leadership moats across industries, Drbul added.

27
May
14
Sep

AMZN Amazon.com

$2,467.00 / +96.7 (+4.08%)

05/01/20 Susquehanna: Amazon.com price target raised to $3000 from $2500 at Susquehanna

05/01/20 Morgan Stanley: Amazon.com price target raised to $2,600 from $2,400 at Morgan Stanley

05/01/20 KeyBanc: Amazon.com price target raised to $2,700 from $2,400 at KeyBanc

05/01/20 Stifel: Stifel says Amazon 'doing all the right things for society'

TODAY'S FREE FLY STORIES

Hot Stocks	Camping World announces deal to acquire EZ Living RV in Illinois » 08:10 03/02/21 03/02 08:10 03/02/21 08:10 CWH Camping World $33.67 / +2.39 (+7.64%) Camping World Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options CWH Camping World $33.67 / +2.39 (+7.64%) 03/01/21 Camping World to acquire Triple A R.V. Center in Oregon 02/22/21 Camping World to acquire Lee's Family Trailer in Windham, ME, terms undisclosed 02/18/21 Camping World to acquire two dealerships in Massachusetts, one in Connecticut 02/17/21 Camping World acquires two locations in the Northeast CWH Camping World $33.67 / +2.39 (+7.64%) 02/26/21 JPMorgan Camping World price target raised to $52 from $45 at JPMorgan 01/25/21 Northcoast Camping World upgraded to Buy from Neutral at Northcoast 01/20/21 Monness Crespi Peer's results show positive read-through for Camping World, says Monness Crespi 12/16/20 JPMorgan JPMorgan reiterates $45 target on Camping World after Lordstown pact CWH Camping World $33.67 / +2.39 (+7.64%) 02/26/21 Camping World sees FY21 adjusted EBITDA $640M-$690M 02/25/21 Camping World reports Q4 EPS 48c, consensus 26c 11/02/20 Camping World CEO confirms previously issued FY21 adjusted EBITDA target 11/02/20 Camping World raises FY20 adjusted EBITDA view to $495M-$515M from $460M-$490M 20 Aug CWH Camping World $33.67 / +2.39 (+7.64%) 12/15/20 Lordstown, Camping World to make 'special announcement,' WKBN says CWH Camping World $33.67 / +2.39 (+7.64%) 01/30/21 Charged: Tesla reports first profit miss in over a year 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 11/16/20 Fly Insider: Cerevel Therapeutics, Paylocity among weeks notable insider trades 11/02/20 Fly Intel: Wall Street's top stories for Monday CWH Camping World $33.67 / +2.39 (+7.64%) 01/28/21 Camping World put volume heavy and directionally bearish 01/22/21 Camping World call volume above normal and directionally bullish 01/21/21 Camping World call volume above normal and directionally bullish 12/16/20 Call trader flips Camping World calls for 1day loss
Hot Stocks	Cerence, ECARX to partner with Lotus Cars on voice-powered tech » 08:10 03/02/21 03/02 08:10 03/02/21 08:10 CRNC Cerence $117.60 / +6.12 (+5.49%) Cerence announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CRNC Cerence $117.60 / +6.12 (+5.49%) 02/10/21 Cerence introduces Cerence Tour Guide application 01/26/21 Cerence appoints Sujal Shah as Head of Professional Services 01/21/21 Cerence installs two cloud centers in Japana with Toyota as first user 01/19/21 Cerence to unveil next-generation product portfolio CRNC Cerence $117.60 / +6.12 (+5.49%) 02/10/21 Raymond James Cerence price target raised to $130 from $80 at Raymond James 02/09/21 Craig-Hallum Cerence price target raised to $135 from $90 at Craig-Hallum 02/09/21 Wedbush Cerence price target raised to $150 from $120 at Wedbush 02/09/21 RBC Capital Cerence price target raised to $105 from $88 at RBC Capital CRNC Cerence $117.60 / +6.12 (+5.49%) 02/08/21 Cerence sees 2021 revenue $370M-$380M, consensus $377.56M 02/08/21 Cerence sees Q2 revenue $92M-$95M, consensus $92.99M 02/08/21 Cerence reports Q1 adjusted EPS 59c, consensus 51c 11/16/20 Cerence sees 2021 revenue $360M-$380M, consensus $356.64M CRNC Cerence $117.60 / +6.12 (+5.49%) 09/22/20 Cerence 'belongs in the SaaS trash junkyard,' short-seller says CRNC Cerence $117.60 / +6.12 (+5.49%) 11/16/20 Fly Intel: Pre-market Movers 03/15/21 33rd Annual Roth Virtual Conference
Hot Stocks	Atlas subsidiary to acquire two 15,000 TEU scrubber-fitted containerships » 08:10 03/02/21 03/02 08:10 03/02/21 08:10 ATCO Atlas Corp. $13.47 / +0.04 (+0.30%) Seaspan, a wholly owned… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events ATCO Atlas Corp. $13.47 / +0.04 (+0.30%) 02/12/21 Seaspan announces 10 dual-fuel LNG containership newbuilds 02/12/21 ZIM Integrated, Atlas' Seaspan sign long-term charter for 10 LNG-fueled vessels 02/08/21 Seaspan announces newbuild order for two 24,000 TEU containerships 01/11/21 Atlas Corp. names Graham Talbot as CFO ATCO Atlas Corp. $13.47 / +0.04 (+0.30%) 02/04/21 B. Riley Securities Atlas Corp. initiated with a Buy, $16.50 target at B. Riley 02/04/21 B. Riley Securities Atlas Corp. initiated with a Buy at B. Riley Securities 12/07/20 Stifel Atlas Corp. price target raised to $11 from $9.50 at Stifel 10/30/20 BMO Capital Atlas Corp. price target lowered to C$46 from C$47 at BMO Capital 03/15/21 2021 Industrials Virtual Conference 03/09/21 Atlas Corp. - ATCO 03/23/21 Atlas Corporation
Hot Stocks	Vislink awarded $4M DOD order for handheld ISR receiver devices, accessories » 08:09 03/02/21 03/02 08:09 03/02/21 08:09 VISL Vislink $3.32 / +0.085 (+2.63%) Vislink announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Options VISL Vislink $3.32 / +0.085 (+2.63%) 02/17/21 Vislink appoints Joe Carson as VP, global operations and service 02/09/21 Vislink providing antennas to Asharq News in Arab capitals 01/27/21 Vislink begins shipping DVE6100 Encoder equipment 01/07/21 Vislink launches IP Link 3.0 VISL Vislink $3.32 / +0.085 (+2.63%) 02/17/21 Five new option listings and two option delistings on February 17th
Upgrade	LyondellBasell upgraded to Overweight from Equal Weight at Wells Fargo » 08:09 03/02/21 03/02 08:09 03/02/21 08:09 LYB LyondellBasell $106.34 / +3.145 (+3.05%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly LYB LyondellBasell $106.34 / +3.145 (+3.05%) 02/17/21 Halliburton appoints Bob Patel to board of directors 01/26/21 LyondellBasell, Sinopec Shanghai sign agreement to form JV to produce PO and SM 12/07/20 LyondellBasell, SUEZ jointly announce the acquisition of TIVACO 10/02/20 LyondellBasell to acquire 50% of Sasol Louisiana assets for $2B in JV agreement LYB LyondellBasell $106.34 / +3.145 (+3.05%) 03/01/21 Alembic Global LyondellBasell upgraded to Overweight from Neutral at Alembic Global 02/22/21 BofA LyondellBasell upgraded to Buy from Neutral at BofA 02/22/21 BofA LyondellBasell upgraded to Buy from Neutral at BofA 02/02/21 Fly Intel: Top five analyst upgrades LYB LyondellBasell $106.34 / +3.145 (+3.05%) 01/29/21 LyondellBasell reports Q4 ex-items EPS $2.19, consensus $1.36 10/30/20 LyondellBasell reports Q3 ex-items EPS $1.27, consensus $1.12 10/29/20 Notable companies reporting before tomorrow's open 10/29/20 Notable companies reporting before tomorrow's open LYB LyondellBasell $106.34 / +3.145 (+3.05%) 11/13/20 Disney upgrade among today's top calls on Wall Street

Conference/Events	Caesarstone participates in a conference call with Benchmark » 08:08 03/02/21 03/02 08:08 03/02/21 08:08 CSTE Caesarstone $12.84 / +0.1 (+0.78%) Construction Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events CSTE Caesarstone $12.84 / +0.1 (+0.78%) 01/06/21 Caesarstone acquires Omicrom for an enterprise value of approximately $27M CSTE Caesarstone $12.84 / +0.1 (+0.78%) 12/29/20 Benchmark Benchmark starts 'rare housing vaccine play' Caesarstone at Buy 12/29/20 Benchmark Caesarstone initiated with a Buy at Benchmark CSTE Caesarstone $12.84 / +0.1 (+0.78%) 12/29/20 Fly Intel: Wall Street's top stories for Tuesday 12/29/20 Fly Intel: Wall Street's top stories at midday 03/03/21 Caesarstone - CSTE 00:00 Today Caesarstone 03/03/21 Caesarstone
Hot Stocks	Biocept, Aegea Biotechnologies announce supply agreement » 08:08 03/02/21 03/02 08:08 03/02/21 08:08 BIOC Biocept $6.44 / +0.3 (+4.89%) Aegea Biotechnologies and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options BIOC Biocept $6.44 / +0.3 (+4.89%) 02/24/21 Biocept to collaborate with BioDiagnostics for treatment of NSCLC patients 02/03/21 Biocept has received over 250,000 COVID-19 testing samples 01/12/21 Biocept CEO says well positioned to grow liquid biopsy oncology business 12/30/20 Biocept enters laboratory services agreements with physician associations BIOC Biocept $6.44 / +0.3 (+4.89%) 08/13/20 Maxim Biocept price target raised to $2 from $1 at Maxim 05/14/20 Brookline Biocept initiated with a Buy at Brookline BIOC Biocept $6.44 / +0.3 (+4.89%) 11/12/20 Biocept reports Q3 EPS ($2.47), consensus (47c) 14 Apr BIOC Biocept $6.44 / +0.3 (+4.89%) 11/12/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference BIOC Biocept $6.44 / +0.3 (+4.89%) 11/16/20 Sixteen new option listings and one option delisting on November 16th
Hot Stocks	Luokung Technology seeks clarification of deadline from DoD list » 08:08 03/02/21 03/02 08:08 03/02/21 08:08 LKCO Luokung Technology $1.51 / -0.06 (-3.82%) Luokung Technology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News On The Fly LKCO Luokung Technology $1.51 / -0.06 (-3.82%) 02/22/21 Luokung Technology announces closing of $100M registered direct offering 02/04/21 Luokung Technology's acquisition candidate enters autonomous driving partnership 01/15/21 Luokung Technology: 'Not owned, controlled or affiliated by Chinese military' 12/09/20 Luokung Technology signs marketing agreement with Yiting LKCO Luokung Technology $1.51 / -0.06 (-3.82%) 02/17/21 Fly Intel: Wall Street's top stories for Wednesday 02/17/21 Fly Intel: Wall Street's top stories at midday
Hot Stocks	ING Groep reviews strategic options for retail banking operations in Austria » 08:08 03/02/21 03/02 08:08 03/02/21 08:08 ING ING Groep $11.10 / +0.24 (+2.21%) ING is announcing that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals ING ING Groep $11.10 / +0.24 (+2.21%) 02/18/21 ING to leave Czech retail banking market by end of year 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 11/06/20 ING Groep to appoint Ljiljana Cortan as chief risk officer ING ING Groep $11.10 / +0.24 (+2.21%) 03/01/21 Berenberg ING Groep price target raised to EUR 10.70 from EUR 8.40 at Berenberg 02/24/21 Barclays ING Groep price target raised to EUR 9 from EUR 8.40 at Barclays 02/19/21 AlphaValue ING Groep upgraded to Add from Sell at AlphaValue 02/15/21 Morgan Stanley ING Groep upgraded to Overweight from Equal Weight at Morgan Stanley ING ING Groep $11.10 / +0.24 (+2.21%) 02/12/21 ING Groep reports Q4 net result per share EUR 0.19 vs. EUR 0.23 last year 11/05/20 ING Groep reports Q3 net result per share EUR 0.20 vs. EUR 0.35 last year ING ING Groep $11.10 / +0.24 (+2.21%) 01/12/21 UBS chairman backs CEO Ralph Hamers after probe, Bloomberg reports 12/09/20 UBS backs new CEO Ralph Hamers amid probe, FT reports
Hot Stocks	Agilent to acquire Resolution Bioscience for $550M » 08:07 03/02/21 03/02 08:07 03/02/21 08:07 A Agilent $124.52 / +2.345 (+1.92%) Agilent Technologies … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options A Agilent $124.52 / +2.345 (+1.92%) 02/22/21 Agilent reports FDA approval for expanded use of companion diagnostic in NSCLC 02/18/21 Agilent launches Agilent Dako SARS-CoV-2 IgG ELISA kit 02/16/21 Ackman's Pershing Square decreases Lowe's stake in Q4 02/16/21 Agilent board authorizes $2B stock buyback A Agilent $124.52 / +2.345 (+1.92%) 02/17/21 Baird Agilent price target raised to $137 from $133 at Baird 02/17/21 SVB Leerink Agilent price target raised to $140 from $130 at SVB Leerink 02/17/21 Wells Fargo Agilent price target raised to $140 from $120 at Wells Fargo 02/17/21 KeyBanc Agilent price target raised to $148 from $130 at KeyBanc A Agilent $124.52 / +2.345 (+1.92%) 02/16/21 Agilent sees FY21 EPS $3.80-$3.90, consensus $3.71 02/16/21 Agilent sees Q2 EPS 78c-80c, consensus 83c 02/16/21 Agilent reports Q1 EPS $1.06, consensus 89c 02/16/21 Notable companies reporting after market close A Agilent $124.52 / +2.345 (+1.92%) 11/23/20 Fly Intel: After-Hours Movers 00:00 Today 41st Annual Healthcare Virtual Conference 03/17/21 Agilent Technologies, Inc. A Agilent $124.52 / +2.345 (+1.92%) 02/17/21 Early notable gainers among liquid option names on February 17th

Earnings	AMMO sees 2022 revenue $120M » 08:07 03/02/21 03/02 08:07 03/02/21 08:07 POWW AMMO $7.13 / +0.15 (+2.15%) The Company expects… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Syndicate Options POWW AMMO $7.13 / +0.15 (+2.15%) 02/11/21 AMMO enters into LOI with IA Tech for its GunBroker.com business 02/04/21 AMMO reports 256% y-o-y increase in orders shipped 02/02/21 AMMO restarts upgraded 50 caliber production line 01/20/21 AMMO appoints Richard Childress to board of directors POWW AMMO $7.13 / +0.15 (+2.15%) 01/26/21 AMMO expects Q3 revenue in excess of $16.5M, one est. $12.01M 01/04/21 AMMO sees Q3 revenue in excess of $16.5M, one est. $12.01M 12/08/20 AMMO reaffirms 2021 revenue view of $55M vs. $14.8M last year 12/08/20 AMMO sees Q2 revenue $15M vs. $2.8M last year 01 Dec POWW AMMO $7.13 / +0.15 (+2.15%) 02/11/21 Unusually active option classes on open February 11th 02/04/21 Unusually active option classes on open February 4th 01/08/21 Largest borrow rate increases among liquid names 01/06/21 Fifteen new option listings on January 6th
Hot Stocks	Dine Brands sees FY21 capital expenditures $14M » 08:07 03/02/21 03/02 08:07 03/02/21 08:07 DIN Dine Brands $81.63 / +1.895 (+2.38%) As of December 31, 2020,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events DIN Dine Brands $81.63 / +1.895 (+2.38%) 11/17/20 Dine Brands names John Peyton, president and CEO DIN Dine Brands $81.63 / +1.895 (+2.38%) 02/10/21 Deutsche Bank Dine Brands downgraded to Hold from Buy at Deutsche Bank 01/20/21 Wedbush Dine Brands added to Best List Ideas, target raised to $83 at Wedbush 01/06/21 Raymond James Dine Brands upgraded to Outperform from Market Perform at Raymond James 01/06/21 Raymond James Dine Brands upgraded to Outperform from Market Perform at Raymond James DIN Dine Brands $81.63 / +1.895 (+2.38%) 08:05 Today Dine Brands reports Q4 adjusted EPS 39c, consensus 67c 10/28/20 Dine Brands reports Q3 EPS 80c, consensus 36c 12:00 Today Dine Brands - DIN
Initiation	Immunocore initiated with a Buy at Jefferies » 08:07 03/02/21 03/02 08:07 03/02/21 08:07 IMCR Immunocore $50.10 / +2.77 (+5.85%) Jefferies analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly IMCR Immunocore $50.10 / +2.77 (+5.85%) 02/19/21 Immunocore's tebentafusp granted Breakthrough Therapy Designation IMCR Immunocore $50.10 / +2.77 (+5.85%) 07:20 Today JPMorgan Immunocore initiated with an Overweight at JPMorgan 05:04 Today Goldman Sachs Immunocore initiated with a Neutral at Goldman Sachs 05 Feb IMCR Immunocore $50.10 / +2.77 (+5.85%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech
Hot Stocks	Soliton selects RESONIC as brand name for FDA-cleared RAP device » 08:06 03/02/21 03/02 08:06 03/02/21 08:06 SOLY Soliton $13.05 / -0.3 (-2.25%) Soliton announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events SOLY Soliton $13.05 / -0.3 (-2.25%) 02/23/21 Soliton announces pre-clinical study in animals on liver fibrosis 02/01/21 Soliton announces FDA clearance of its RAP technology 01/26/21 Soliton announces collaboration with U.S. Navy for RAP device 11/02/20 Soliton appoints Brad Hauser as CEO SOLY Soliton $13.05 / -0.3 (-2.25%) 02/08/21 Maxim Soliton price target raised to $25 from $22 at Maxim 02/02/21 Cantor Fitzgerald Soliton price target raised to $20 from $12 at Cantor Fitzgerald 07/15/20 Cantor Fitzgerald Soliton initiated with an Overweight at Cantor Fitzgerald 06/16/20 Roth Capital Soliton price target raised to $16 from $14 at Roth Capital SOLY Soliton $13.05 / -0.3 (-2.25%) 11/12/20 Soliton reports Q3 EPS (17c), consensus (17c) 26 Jun 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/04/21 Soliton - SOLY
Hot Stocks	Vincera Pharma appoints Hermes Garban as CMO, Hans-Georg Lerchen as CSO » 08:06 03/02/21 03/02 08:06 03/02/21 08:06 VINC Vincera Pharma $19.24 / +0.23 (+1.21%) Vincerx Pharma announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events VINC Vincera Pharma $19.24 / +0.23 (+1.21%) 02/24/21 Vincera Pharma to host KOL webinar on VIP152 01/07/21 Vincera Pharma changes name to Vincerx 12/23/20 Vincera Pharma comples business combination with LifeSci Acquisition VINC Vincera Pharma $19.24 / +0.23 (+1.21%) 01/06/21 Chardan Vincera Pharma initiated with a Buy at Chardan VINC Vincera Pharma $19.24 / +0.23 (+1.21%) 09/29/20 Fly Intel: Wall Street's top stories at midday 03/05/21 Vincera Pharma - VINC

Upgrade	Dentsply Sirona upgraded to Outperform from Market Perform at Barrington » 08:06 03/02/21 03/02 08:06 03/02/21 08:06 XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) Barrington analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 01/04/21 Dentsply Sirona acquires Byte in $1.04B all-cash deal 01/04/21 Dentsply Sirona acquires Byte in $1.04B all cash deal XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 08:03 Today Barrington Dentsply Sirona upgraded to Outperform from Market Perform at Barrington 07:05 Today Barclays Dentsply Sirona price target raised to $55 from $50 at Barclays 06:49 Today Baird Dentsply Sirona price target raised to $71 from $62 at Baird 06:11 Today H.C. Wainwright Dentsply Sirona price target raised to $60 from $55 at H.C. Wainwright XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Dentsply Sirona sees FY21 adjusted EPS $2.60-$2.80, consensus $2.39 03/01/21 Dentsply Sirona reports Q4 adjusted EPS 87c, consensus 64c 11/05/20 Dentsply Sirona reports Q3 non-GAAP EPS 67c, consensus 32c 11/04/20 Notable companies reporting before tomorrow's open XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Fly Intel: Pre-market Movers 11/05/20 Fly Intel: Pre-market Movers XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Early notable gainers among liquid option names on March 1st 10/22/20 Early notable gainers among liquid option names on October 22nd
Hot Stocks	Lionsgate and STARZ close output deal » 08:06 03/02/21 03/02 08:06 03/02/21 08:06 LGF.A Lionsgate $15.65 / +1.12 (+7.71%) Lionsgate and premium… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly LGF.A Lionsgate $15.65 / +1.12 (+7.71%) 02/26/21 Lionsgate, Sony Pictures enter multi-year distribution agreement 12/22/20 Sony Pictures CEO says 'don't think' will move to 'day and date' film releases 12/02/20 Starz announces launch of direct to consumer 'Lionsgate Play' in India LGF.A Lionsgate $15.65 / +1.12 (+7.71%) 02/08/21 Deutsche Bank Lionsgate price target raised to $16 from $12 at Deutsche Bank 02/05/21 RBC Capital Lionsgate price target raised to $13 from $7 at RBC Capital 01/28/21 Macquarie Lionsgate price target raised to $18 from $12 at Macquarie 11/10/20 Deutsche Bank Lionsgate price target raised to $12 from $10 at Deutsche Bank LGF.A Lionsgate $15.65 / +1.12 (+7.71%) 02/04/21 Lionsgate reports Q3 adjusted EPS 21c, consensus (11c) 11/05/20 Lionsgate reports Q2 adjusted EPS 33c, consensus (3c) 11/05/20 Notable companies reporting after market close LGF.A Lionsgate $15.65 / +1.12 (+7.71%) 12/10/20 Disney, NBCUniversal unlikely to follow WarnerMedia's 2021 media plan, CNBC says 11/05/20 Lionsgate laying off about 15% of motion picture unit staff, Variety says LGF.A Lionsgate $15.65 / +1.12 (+7.71%) 11/05/20 Fly Intel: After-Hours Movers 10/04/20 Box Office Battle: 'Tenet' stays on top as box office recovery collapses 09/27/20 Box Office Battle: 'Tenet' stays on top, nears $300M globally 09/25/20 Box Office Battle: 'Tenet' expected to remain #1, other films delay openings
Recommendations	AudioEye price target raised to $42 from $36 at Maxim » 08:06 03/02/21 03/02 08:06 03/02/21 08:06 AEYE AudioEye $33.67 / +2.26 (+7.20%) Maxim analyst Allen Klee… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly AEYE AudioEye $33.67 / +2.26 (+7.20%) 03/01/21 AudioEye announces Zach Okun as chief product officer 02/08/21 AudioEye Inc trading resumes 02/08/21 AudioEye Inc trading halted, volatility trading pause 12/01/20 AudioEye announces Rob Ulveling as chief business officer AEYE AudioEye $33.67 / +2.26 (+7.20%) 02/08/21 Maxim AudioEye initiated with a Buy at Maxim 01/08/21 B. Riley Securities AudioEye price target raised to $32 from $25 at B. Riley Securities 09/01/20 B. Riley FBR AudioEye price target raised to $25 from $21 at B. Riley FBR 05/15/20 B. Riley FBR AudioEye price target raised to $14.50 from $11.50 at B. Riley FBR AEYE AudioEye $33.67 / +2.26 (+7.20%) 11/12/20 AudioEye reports Q3 non-GAAP EPS (2c), consensus (32c) 27 Aug AEYE AudioEye $33.67 / +2.26 (+7.20%) 11/12/20 Fly Intel: After-Hours Movers
Earnings	Dine Brands reports Q4 adjusted EPS 39c, consensus 67c » 08:05 03/02/21 03/02 08:05 03/02/21 08:05 DIN Dine Brands $81.63 / +1.895 (+2.38%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events DIN Dine Brands $81.63 / +1.895 (+2.38%) 11/17/20 Dine Brands names John Peyton, president and CEO DIN Dine Brands $81.63 / +1.895 (+2.38%) 02/10/21 Deutsche Bank Dine Brands downgraded to Hold from Buy at Deutsche Bank 01/20/21 Wedbush Dine Brands added to Best List Ideas, target raised to $83 at Wedbush 01/06/21 Raymond James Dine Brands upgraded to Outperform from Market Perform at Raymond James 01/06/21 Raymond James Dine Brands upgraded to Outperform from Market Perform at Raymond James DIN Dine Brands $81.63 / +1.895 (+2.38%) 10/28/20 Dine Brands reports Q3 EPS 80c, consensus 36c 12:00 Today Dine Brands - DIN
Hot Stocks	StoneX Group acquires minority stake in Tigress Financial Partners » 08:05 03/02/21 03/02 08:05 03/02/21 08:05 SNEX StoneX Group $60.28 / +1.83 (+3.13%) StoneX Group announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research SNEX StoneX Group $60.28 / +1.83 (+3.13%) 01/10/21 StoneX, City Index announce four-year sponsorship deal with Saracens Rugby 10/15/20 StoneX Group Chairman Radziwill sells over $356K in company shares SNEX StoneX Group $60.28 / +1.83 (+3.13%) 11/11/20 Fly Intel: Top five analyst initiations 11/11/20 Jefferies StoneX Group initiated with a Buy at Jefferies

Hot Stocks	Aqua Metals appoints Molly Zhang, Edward Smith to board » 08:04 03/02/21 03/02 08:04 03/02/21 08:04 AQMS Aqua Metals $5.17 / +0.42 (+8.84%) , SMTX SMTC Corp. $5.89 / +0.035 (+0.60%) Aqua Metals, Inc. (AQMS)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events AQMS SMTX AQMS Aqua Metals $5.17 / +0.42 (+8.84%) 02/23/21 Aqua Metals files provisional patent for lithium-ion battery recycling 02/17/21 Aqua Metals invests $2M in LiNiCo 02/17/21 Comstock Mining secures majority interest in LiNiCo 02/16/21 Aqua Metals reaches agreement with recycler to lease-to-buy AquaRefinery SMTX SMTC Corp. $5.89 / +0.035 (+0.60%) 01/04/21 SMTC Corp. trading resumes 01/04/21 SMTC Corp. to merge with H.I.G. Capital affiliate for $6.044 per share 01/04/21 SMTC Corp. trading halted, news dissemination 11/16/20 SMTC Corp. to manufacture Aura V ventilators for IPM Chirana AQMS SMTX AQMS Aqua Metals $5.17 / +0.42 (+8.84%) 03/12/20 Oppenheimer Aqua Metals price target lowered to $2 from $9 at Oppenheimer SMTX SMTC Corp. $5.89 / +0.035 (+0.60%) 01/04/21 Craig-Hallum SMTC Corp. downgraded to Hold from Buy at Craig-Hallum 11/05/20 B. Riley Securities SMTC Corp. price target raised to $7 from $6 at B. Riley Securities 03/31/21 SMTC Corp.
Earnings	WhiteHorse Finance reports Q4 core EPS 35c, consensus 32c » 08:04 03/02/21 03/02 08:04 03/02/21 08:04 WHF WhiteHorse Finance $14.62 / -0.05 (-0.34%) Reports Q4 Net Asset… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events WHF WhiteHorse Finance $14.62 / -0.05 (-0.34%) 10/09/20 WhiteHorse Finance announces special distribution of 12.5c per share WHF WhiteHorse Finance $14.62 / -0.05 (-0.34%) 11/24/20 B. Riley Securities WhiteHorse Finance price target raised to $13 from $11 at B. Riley Securities 05/12/20 National Securities WhiteHorse Finance upgraded to Buy from Neutral at National Securities 03/24/20 B. Riley FBR WhiteHorse Finance downgraded to Neutral from Buy at B. Riley FBR 03/17/20 National Securities WhiteHorse Finance upgraded to Buy from Neutral at National Securities WHF WhiteHorse Finance $14.62 / -0.05 (-0.34%) 11/09/20 WhiteHorse Finance reports Q3 EPS 36c, consensus 29c 14:30 Today WhiteHorse Finance - WHF
Hot Stocks	Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX » 08:04 03/02/21 03/02 08:04 03/02/21 08:04 GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) Cipla announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) 02/24/21 J&J's Janssen announces submission of sNDA to FDA for expanded Cabenuva use 02/24/21 ViiV Healthcare submits sNDA to FDA for HIV treatment Cabenuva 02/22/21 Sanofi, GSK initiate Phase 2 study of COVID-19 vaccine candidate 02/17/21 GlaxoSmithKline, Vir expand coronavirus collaboration for respiratory viruses GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) 02/12/21 Morgan Stanley GlaxoSmithKline price target lowered to 1,580 GBp at Morgan Stanley 02/11/21 Berenberg GlaxoSmithKline price target lowered to 1,570 GBp from 1,720 GBp at Berenberg 02/09/21 JPMorgan GlaxoSmithKline price target lowered to 1,300 GBp from 1,500 GBp at JPMorgan 02/08/21 UBS GlaxoSmithKline price target lowered to 1,320 GBp from 1,450 GBp at UBS GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) 02/03/21 GlaxoSmithKline reports Q4 adjusted EPS 23.3p vs. 24.8p a year ago 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) 02/09/21 Teva wins new hearing on $235M GSK patent verdict, Bloomberg reports 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/17/21 Fly Intel: Pre-market Movers 02/11/21 Fly Intel: Wall Street's top stories for Thursday 00:00 Today 2021 London Global Healthcare Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference GSK GlaxoSmithKline $33.74 / +0.13 (+0.39%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish
Periodicals	Merck to help produce J&J Covid vaccine, Washington Post reports » 08:03 03/02/21 03/02 08:03 03/02/21 08:03 MRK Merck $72.37 / -0.28 (-0.39%) , JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) President Biden will… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MRK JNJ MRK Merck $72.37 / -0.28 (-0.39%) 03/01/21 Merck announces voluntary withdrawal for KEYTRUDA in SCLC 03/01/21 Merck: FDA accepts gefapixant New Drug Application for review 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash 02/25/21 Merck, Pandion Therapeutics deal has approx. total equity value of $1.85B JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA MRK JNJ MRK Merck $72.37 / -0.28 (-0.39%) 02/25/21 SVB Leerink Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink 02/25/21 Morgan Stanley Pandion downgraded to Equal Weight from Overweight at Morgan Stanley 02/17/21 William Blair William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ 01/21/21 Wedbush Scholar Rock price target raised to $66 from $47 at Wedbush JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MRK JNJ MRK Merck $72.37 / -0.28 (-0.39%) 02/04/21 Merck sees FY21 adjusted EPS $6.48-$6.68, consensus $6.41 02/04/21 Merck reports Q4 adjusted EPS $1.32, consensus $1.38 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open MRK JNJ MRK Merck $72.37 / -0.28 (-0.39%) 02/10/21 Merck in talks to produce authorized COVID-19 vaccines, WSJ says 02/03/21 Records show Merck's Propecia has trail of suicide reports, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 06:20 Today Johnson & Johnson Covid-19 vaccine shipments begin rollout, WSJ reports 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says MRK JNJ MRK Merck $72.37 / -0.28 (-0.39%) 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: Pre-market Movers 02/04/21 Fly Intel: Wall Street's top stories for Thursday JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 04/09/21 Pharma/Biopharma 00:00 Today 41st Annual Healthcare Virtual Conference 04/20/21 Johnson & Johnson - JNJ 04/29/21 Merck - MRK 03/29/21 PDUFA Date for KEYTRUDA 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 11/28/21 PDUFA Date for KEYTRUDA (Phase 3 KEYNOTE-355 Trial) MRK JNJ MRK Merck $72.37 / -0.28 (-0.39%) 02/17/21 Merck call volume above normal and directionally bullish 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th
Upgrade	Dentsply Sirona upgraded to Outperform from Market Perform at Barrington » 08:03 03/02/21 03/02 08:03 03/02/21 08:03 XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) Barrington analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 01/04/21 Dentsply Sirona acquires Byte in $1.04B all-cash deal 01/04/21 Dentsply Sirona acquires Byte in $1.04B all cash deal XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 07:05 Today Barclays Dentsply Sirona price target raised to $55 from $50 at Barclays 06:49 Today Baird Dentsply Sirona price target raised to $71 from $62 at Baird 06:11 Today H.C. Wainwright Dentsply Sirona price target raised to $60 from $55 at H.C. Wainwright 03/01/21 Piper Sandler Dentsply Sirona price target raised to $70 from $63 at Piper Sandler XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Dentsply Sirona sees FY21 adjusted EPS $2.60-$2.80, consensus $2.39 03/01/21 Dentsply Sirona reports Q4 adjusted EPS 87c, consensus 64c 11/05/20 Dentsply Sirona reports Q3 non-GAAP EPS 67c, consensus 32c 11/04/20 Notable companies reporting before tomorrow's open XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Fly Intel: Pre-market Movers 11/05/20 Fly Intel: Pre-market Movers XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Early notable gainers among liquid option names on March 1st 10/22/20 Early notable gainers among liquid option names on October 22nd

Events

Earnings calls, analyst events, roadshows and more

TGTX
Today at 08:30

TG Therapeutics - TGTX Conference Calls
HNGR
Today at 08:30

Hanger - HNGR Conference Calls
RNLX
Today at 08:30

Renalytix AI - RNLX Conference Calls
NNOX
Today at 08:30

Nano-X Imaging - NNOX Conference Calls
ANF
Today at 08:30

Abercrombie & Fitch - ANF Conference Calls
ATRS
Today at 08:30

Antares Pharma - ATRS Conference Calls
DDD
Today at 08:30

3D Systems - DDD Conference Calls
MDCA
Today at 08:30

MDC Partners - MDCA Conference Calls
KTB
Today at 08:30

Kontoor Brands - KTB Conference Calls
TTEC
Today at 08:30

TTEC Holdings - TTEC Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley $84.00-84.50 1.2M Shares FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley $166.50-169.95 1.5M Shares HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan $88.25-89.25 1.45M Shares RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 12M Shares OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $32.00-34.00 31M Shares ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: Wells Fargo, Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Amazon.com price target raised to $2,700 from $2,250 at Guggenheim

TODAY'S FREE FLY STORIES

Get Full Fly Access